LBRX vs TFX · $803.4M cap vs P/E 2083, rev $1.12B
LB Pharmaceuticals Inc Common Stock (LBRX) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company listed on NASDAQ.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
LBRX does not have a complete income-statement cache yet.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
LBRX currently screens at market cap $803.4M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the LBRX and TFX stock pages for the full models.
Not investment advice.